INFRASTRUCTURE. OligoNova Hub is Sweden’s new national infrastructure for drug development, specifically focused on therapeutic oligonucleotides. Here, researchers with expertise in e.g. bioinformatics, chemistry and cellular biology will work with innovative development projects of drugs for patient groups that currently lack appropriate treatment. Pär Matsson, professor of pharmacokinetics at the Department of Pharmacology, Sahlgrenska Academy, is head of the OligoNova Hub. “My research focuses on drug development, especially how to…
Anders Rosengren receives Swedish Heart Lung Foundation’s Prevention Grant
GRANTS. This year’s recipient of the Swedish Heart Lung Foundation’s prevention grant of SEK 3 million is Anders Rosengren, a professor at the University of Gothenburg. He heads a project to investigate how a digital tool might help prevent cardiovascular disease. “Anders Rosengren’s study may open up a new way of preventing cardiovascular disease. The tool can easily be used by many people free of charge to encourage healthy living…
Antidepressants linked to lower suicide risk among 75+ in residential care
NEW STUDY. Lower suicide risk was seen in older adults aged 75+ residing in long-term care facilities who were prescribed antidepressants. Suicide risk was doubled in those who were on medication for sleep problems according to a study published in International Journal of Geriatric Psychiatry. Despite the increasing number of older people who need long-term care and who often experience stressful life transitions and psychiatric conditions that increase risk of…
Atrial fibrillation and dementia clearly associate
DOCTORAL THESIS. For people with atrial fibrillation, one of our most common cardiac disorders, dementia risk is elevated. This is shown by a University of Gothenburg thesis based on research at population level. Atrial fibrillation (AF), a common heart condition in older people, is characterized by irregular and often rapid heartbeats. These symptoms may be chronic, or come and go, and many people have the condition without being aware of…
Anders Rosengren invited to Swedish Riksdag’s Research Day
INTERACTION. Anders Rosengren participated in the Swedish Riksdag’s Research Day on February 24 to discuss how we can better treat and prevent lifestyle diseases such as type II diabetes. He was invited by the Riksdag’s Committee on Health and Welfare and participated in one of the parallel seminars. Anders Rosengren’s lecture addressed the general state of research surrounding the importance of lifestyle habits for the major common diseases, his own…